机构地区:[1]上海交通大学医学院附属瑞金医院肾脏科,200025
出 处:《中华医学杂志》2006年第11期740-744,共5页National Medical Journal of China
基 金:国家自然科学基金资助项目(30270613);上海市重点学科基金资助项目(T0201)
摘 要:目的研究过氧化物酶体增殖物激活受体γ(PPARγ)激动剂阻断转化生长因子(TGF)β1致肾间质纤维化作用的机制,探讨其抗肾间质纤维化的潜在作用。方法体外培养大鼠肾成纤维细胞株(NRK/49F),观察PPARγ配体15d-PGJ2及其激动剂曲格列酮和齐格列酮对TGFβ1诱导的纤维连接蛋白(FN)mRNA表达的影响。利用Western印迹技术观察PPARγ激动剂对TGFβ1诱导的FN和Smad蛋白表达的影响。结果(1)与1ng/ml TGFβ1组比较,5ng/ml TGFβ1组FN mRNA表达量增加了3.6倍(P〈0.01),5ng/ml TGFβ1刺激24h时较刺激前增加了2.4倍(P〈0.01),TGFβ1诱导FN mRNA表达呈一定范围内的剂量(0—5ne/ml)和时间(0—24h)依赖效应。(2)与5ng/ml TGFβ1组比较,10μmol 15d-PGJ2、曲格列酮和齐格列酮预处理组FN mRNA表达量分别降低37.3%、41.5%和22.7%,FN蛋白表达量分别降低20.6%、38.1%和28.6%。(3)5ng/ml TGFβ1以时间(0.2h)依赖方式诱导p-Smad2/3蛋白表达量增加,作用1h时达到高峰;5ng/ml TGFβ1组p-Smad2/3蛋白表达量较对照组和2ng/ml TGFβ1组分别增加3.42倍和0.97倍。(4)15d-PGJ2、曲格列酮和齐格列酮预处理组p-Smad2/3蛋白表达量与5ng/ml TGFβ1组比较分别降低61.2%、53.0%和59.S%。3种药物干预组之间p-Smad2/3蛋白表达量比较差异无统计学意义,各组Smad2和Smad3蛋白表达量无显著变化。结论PPART激动剂可以抑制TGFβ1诱导的肾间质成纤维细胞细胞外基质合成,其机制可能与阻断TGF-β1/Smad信号途径有关,提示PPARγ激动剂具有抗肾间质纤维化的潜在作用,可能成为延缓终末期肾功能衰竭的治疗新手段之一。Objective To study the effects of peroxisome proliferators-activated receptor (PPABT) ngonists on transforming growth factor (TGF)-β1-induced fibrotic responses in renal fibroblasts, so as to investigate its effects in prevention of tubulointerstitial fibrosis. Methods Bat renal fibroblasts of the line NRK/49F were cultured and divided into groups. In group 1 TGFβ1 of the concentrations of 0, 1, 2, 5, and 10 ng/ml was added and co-cultured for 24 h. In group 2 TGFβ1 of the concentration of 5 ng/ml was added and co-cultured for0, 6, 12, and 24 h respectively. Groups 3, 4, and 5 were pretreated with 10 μmol/L15d-PGJ2, PPAR-/ligand, 10 μmol/L troglitazone, agonist of, and 10 μmol/L ciglitazone, both PPARγ agonists, respectively for 2 h, then treated with 5 ng/ml TGFβ1. A blank control group was sot up. The cultured cells were collected. RT-PCB was used to detect the mRNA expression of TGF-β1-indued fibronectin (FN). Western blotting was used to detect the expression of TGF-β1-lnduced FN, Smad, and pbospbory]ated Smad (p-Smad) proteins. Results TGF-β1 enhanced the FN mRNA expression in a doseand time-dependent manner, The FN mRNA expression of the 5 ng/ml TGF-β1 group was 3.7 times that of the control group (P 〈0.05 ). The FN mRNA expression of the 15d-PGJ2, trnglitazone-, and ciglitasonepretreated groups were lower than that of the 5 ng/nd TGF-β1 group by 37.3%, 41.5%, and 22. 7% respectively (all P 〈 0. 05 ). The p-Smad2/3 protein expression levels of the TGF-β1 group began to increase 15 minutes after stimulation, increased in a time-dependent manner, peaked 1 hour after, and began to decrease 2 hours later. However, the levels of protein expression of total Smad2 and Smad3 did not change significantly in all groups. Both 2 ng/ml TGFβ1 and 5 ng/mlTGFβ1 significantly induced the increase of protein expression of p-Smad2/3 ( all P 〈 0.05 ). The levels of protein expression of p-Smad2 and p-Smad3 of the 5 ng/mlTGFβ1 group were 3.42 and 0.97 times those of the 2 ng/ml
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...